stockrowDr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.
- Revenue
- −10.1%
- EPS
- −36.8%
- Free cash flow
- −70.5%
- Total debt
- +14.1%
Quarter to September 2026, against a year earlier
Follow RDY
Alert me
Dr. Reddy's Laboratories Ltd (RDY) Current ratio
Dr. Reddy's Laboratories Ltd's current ratio at the end of the quarter to 30 September 2026 was 1.9×, up 0.1× from fiscal 2026 (1.8×). Over the past ten years it has ranged from 1.2× (fiscal 2017) to 2.6× (fiscal 2024); the current reading is higher than 42% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 1.8× | (6.06%) |
| FY2025 | 1.9× | (25.77%) |
| FY2024 | 2.6× | 7.11% |
| FY2023 | 2.4× | 24.67% |
| FY2022 | 1.9× | 8.80% |
| FY2021 | 1.8× | (0.66%) |
| FY2020 | 1.8× | (6.72%) |
| FY2019 | 1.9× | 21.93% |
| FY2018 | 1.6× | 33.28% |
| FY2017 | 1.2× | (36.22%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.9× | 1.18% |
| Jun 2026 | 1.9× | 5.68% |
| Mar 2026 | 1.8× | (4.17%) |
| Dec 2025 | 1.9× | 1.51% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| KNSA Kiniksa Pharmaceuticals International, plc compare | 3.9× |
| LNTH Lantheus Holdings, Inc. compare | 3.2× |
| ALKS Alkermes plc compare | 2.4× |
| ELAN Elanco Animal Health Incorporated compare | 2.1× |
| NBIX Neurocrine Biosciences, Inc. compare | 2.0× |
| RDY Dr. Reddy's Laboratories Ltd | 1.9× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 1.9× |
| VTRS Viatris Inc. compare | 1.6× |
| HIMS Hims & Hers Health, Inc. compare | 0.9× |
| Drug Manufacturers Specialty & Generic industry median | 2.4× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on RDY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement